Articles published by Bayer

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Bayer Opens First Co.Lab Life Science Incubator in Cambridge

May 04, 2023

From Bayer

Via Business Wire

Bayer Announces New Strategic Collaboration with New Jersey’s Leading Polytechnic Universities to Cultivate Data Science Talent in Region

April 24, 2023

From Bayer

Via Business Wire

There Is No Room for Allergy Fog This Spring Allergy Season with Claritin®

April 18, 2023

From Bayer

Via Business Wire

Claritin® Takes Aim at Reducing Pollen Levels Through Female Tree Planting Initiative

April 04, 2023

From Bayer

Via Business Wire

Astepro® Allergy Partners with Meghann Fahy to Help Allergy Sufferers Conquer Allergies, Love & Spontaneity Fast

March 30, 2023

From Bayer

Via Business Wire

Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer

March 23, 2023

From Bayer

Via Business Wire

UN 2023 Water Conference: Bayer pledges to help tackle global water crisis with new water strategy

March 21, 2023

From Bayer

Via Business Wire

Bayer collaborates with Microsoft to unveil new cloud-based enterprise solutions, advancing innovation and transparency in the agri-food industry

March 14, 2023

From Bayer

Via Business Wire

Bayer US Joins the Fight to Combat Water Crisis

March 09, 2023

From Bayer

Via Business Wire

World Kidney Day: A Bayer Survey Reveals Physicians Agree on Need for Earlier Testing and Increased Transparent Communication for People Diagnosed With Chronic Kidney Disease Associated With Type 2 Diabetes

March 09, 2023

From Bayer

Via Business Wire

Bayer Unveils the Preceon™ Smart Corn System, Transforming How Farmers Manage Their Corn Crop

March 08, 2023

From Bayer

Via Business Wire

Bayer Expands its “Nutrient Gap Initiative” to Help End Malnutrition

February 23, 2023

From Bayer

Via Business Wire

New NUBEQA® (darolutamide) Subgroup Analyses from the Phase III ARASENS Trial in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients Presented at ASCO GU

February 16, 2023

From Bayer

Via Business Wire

Bill Anderson to Become CEO of Bayer AG

February 08, 2023

From Bayer

Via Business Wire

Bayer Announces First Patients Enrolled in Global Phase III Studies for Investigational Oral FXIa Inhibitor Asundexian

February 08, 2023

From Bayer

Via Business Wire

Bayer Announces Full Commercialization of ThryvOn™ Technology in the U.S., a Unique Cotton Biotech Trait Set to Launch for 2023 Growing Season

February 07, 2023

From Bayer

Via Business Wire

Bayer® Aspirin Continues Long-standing Commitment to Heart Health Education, Encouraging Sports Fans to Keep Their Heart in the Game as the Official Sponsor of Fans’ Hearts

February 06, 2023

From Bayer

Via Business Wire

Phase IIb Clinical Study of Investigational Compound Elinzanetant Evaluated Efficacy and Safety in Postmenopausal Patients with Vasomotor Symptoms Study Findings Published in Menopause: The Journal of The North American Menopause Society

February 02, 2023

From Bayer

Via Business Wire

Bayer Appoints Ben Kampelman as Vice President of Communications for Crop Science North America

January 24, 2023

From Bayer

Via Business Wire

Bayer Acquires Blackford Analysis Ltd. Bolstering the Company’s Position in Digital Medical Imaging

January 18, 2023

From Bayer

Via Business Wire

Bayer to make more than $1.5 Million in Investments in STEAM Education and West Berkeley Resiliency

December 19, 2022

From Bayer

Via Business Wire

Bayer Launches Industry-First Public Database Listing Company’s Science Collaborations and Partnerships in the U.S.

December 06, 2022

From Bayer

Via Business Wire

2022 Radiological Society of North America (RSNA) Annual Meeting: Bayer to showcase product offerings and announces broadened AI offering in Radiology

November 22, 2022

From Bayer

Via Business Wire

Afrin® WOWs Parents with Launch of Children’s Acute Medicated Nasal Sprays – Because One Sick Kid Can Throw Everything Off in An Instant

November 17, 2022

From Bayer

Via Business Wire

Bayer Signs Grant Agreement to Advance Research in Non-Hormonal Contraception

November 08, 2022

From Bayer

Via Business Wire

Outside the US Bayer Extends Development Program for Investigational Product Elinzanetant With Phase III Study in Breast Cancer Patients With Vasomotor Symptoms Caused by Endocrine Therapy

November 07, 2022

From Bayer

Via Business Wire

Bayer to Highlight Additional Analyses From Comprehensive KERENDIA® (finerenone) Clinical Trial Program at the American Society of Nephrology’s 2022 Kidney Week

November 02, 2022

From Bayer

Via Business Wire

Bayer’s KERENDIA® (finerenone) Recommended as Part of Comprehensive Treatment Strategy for Chronic Kidney Disease Associated With Type 2 Diabetes in Newly Published Clinical Recommendations

October 27, 2022

From Bayer

Via Business Wire

Bayer’s KERENDIA® (finerenone) Receives Grade A Recommendation as Treatment Option for Patients With Chronic Kidney Disease Associated With Type 2 Diabetes in Latest Guideline Update From American Association of Clinical Endocrinology

October 10, 2022

From Bayer

Via Business Wire

Bayer Names William Dodero New U.S. General Counsel Beginning January 2023

October 06, 2022

From Bayer

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.